Case presentation {#sec0001}
=================

A 42-years-old woman was admitted to emergency department of our hospital affected by left upper abdominal pain, weakness, and sweatness. She did not have any symptoms before and denied histories of recent trauma. She had undergone splenectomy for a traumatic rupture 20 years before due to a car accident and 3 years later a second operation for abdominal subocclusions caused by adhesions. After these 2 surgical operations there was no evidence of accessory spleen. The patient had not been clinically followed-up since the previous surgery performed in another hospital. At admission the patient was awake, blood pressure was 114/74 mm/Hg, heart rate 81 beats/min, body temperature 37.3°C. At clinical examination, abdomen was distended, and painful on the left side. Laboratory examinations revealed only anemia (HB level 11.5 g/dL; RBC: 3.5 × 10^3^ U/L). US showed an accessory spleen (anteroposterior diameter 50 mm, transverse diameter 45 mm, longitudinal diameter 55 mm) with iperechoic area inside and surrounded by isoipoechoic fluid spill [@bib0002]. In order to perform a better characterization of the lesion, a CECT was performed and revealed a little active spontaneous bleeding inside accessory spleen [@bib0003] ([Fig. 1](#fig0001){ref-type="fig"}). The patient was observed for a week at emergency surgery department. For the persistence of symptoms and the low rate of hemoglobin (11 g/dL) a CECT was performed again; a slight increase of perisplenic liquid fluid spill and a splenic persistent active bleeding were detected. Due to the 2 previous surgical operations in the splenic loggia, the surgeon and the interventional radiologist agreed and decided for endovascular management, so a diagnostic angiography was performed. Celiac trunk angiography was performed with a 5 Fr vascular introducer (Cook Medical, Bloomington, Indiana), followed by selective catheterization of residual splenic artery by using a cobra catheter (Merit Medical, South Jordan, Utah) and a microcatheter Progreat 2.7 Fr., (Terumo, Shibuya*-*ku*,* Tokyo*,* Japan*).* Celiac angiogram demonstrated normal branching pattern [@bib0004]. Selective digital subtraction angiography of the splenic artery showed 2 hypertrophic artery branches [@bib0005] arising from the residual portion of the splenic artery and feeding the accessory spleen hilus [@bib0006] ([Figs. 2](#fig0002){ref-type="fig"}a and b). The microcatheter was then advanced, in selective way, in the hilar branches; no active bleeding was detected, but together with surgeon we decided to embolize both vessels using four microcoils 4 × 2 mm "Tornado" (Cool Medical, Bloomington, Indiana), one microcoil 4 × 3mm "Tornado" and one microcoil 2 × 6 mm "Concerto" (Medtronic B. V. Heerlen, The Netherlands) [@bib0007] ([Fig. 2](#fig0002){ref-type="fig"}c). After embolization neither arterial supply nor further symptoms (fever, pain, alteration on laboratory values) occurred. CECT at 2-day follow-up demonstrated hypoperfusion and reduction of fluid spill ([Fig. 3](#fig0003){ref-type="fig"}). Patient was resigned after 1 week with normal Hb level (13 g/dL) and US at 1-month follow-up detected heterogenous ipoechoic accessory spleen with no blood sign at color-Doppler ([Fig. 4](#fig0004){ref-type="fig"}).Fig. 1CECT Venous phase axial (**A)** and coronal (**B**) shows an accessory spleen (blue star) with a tenuous active bleeding inside (red circle) and perisplenic liquid fluid spill (green arrow). CECT, contrast-enhanced computed tomography. (Color version of figure is available online).Fig 1Fig. 2(**A and B)** Selective DSA of the splenic artery shows 2 hypertrophic artery branches (blue arrows) arising from the residual portion of the splenic artery (black arrow) and feeding the accessory spleen hilus (red star). (C) Selective DSA of residual splenic artery after embolization demonstrates microcoils (green arrows) at hilus with no further opacification of the accessory spleen. DSA, digital subtraction angiography. (Color version of figure is available online).Fig 2Fig. 3CECT 2 days after embolization demonstrates spleen devascularization (blue star) and reduction of fluid spill (green arrow). CECT, contrast-enhanced computed tomography. (Color version of figure is available online).Fig 3Fig. 4(**A)** US 1 month later shows inhomogeneous ipoechoic accessory spleen (green arrow); (**B)** no blood sign at color-Doppler. (Color version of figure is available online).Fig 4

Discussion {#sec0002}
==========

The pathophysiological origin of the accessory spleen and splenosis is different: in particular, the accessory spleen has an embryonic origin due to the lack of fusion of the mesogastric nodules. Splenosis is due to damage of the spleen with consequent self-diffusion of splenic tissue [@bib0008]. Post-traumatic splenosis has a frequency of 67% and various localizations (peritoneum, retroperitoneum, liver, etc.) [@bib0009]. Splenosis cores, unlike the others, are more fragile due to a thinner capsule without elastic tissue. Differently from accessory spleens, splenic implants are fed from the surrounding tissue [@bib0010].

Spontaneous bleeding from accessory spleens and splenosis is extremely rare. According to Guo-Dong Shan review, only 20 cases have been reported in literature, most of them treated with surgery [@bib0011]. In our case, an observational approach had initially been proposed. Lack of improvement in patient\'s clinical condition and previous surgery in the splenic loggia, permitted a minimally invasive endovascular embolization, in agreement with the surgeon. In this case endovascular approach compared to \"Open surgery\" determined a shorter period of hospitalization and a reduction of health cost; besides endovascular embolization causes also less complications than surgery [@bib0012]. In conclusion, despite some drawbacks and feasible complications (such as: bleeding, splenic abscess, and iatrogenic vascular injury), endovascular embolization is a valuable tool in nonoperative management of patients affected by splenosis hemorrhage [@bib0013].
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